Adam Burgoyne is an Oncology physician affiliated with University of San Diego. OpenAlex indexes 113 publications with 5,687 citations (h-index 27); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 W Arbor Dr
San Diego, CA 921039000
Telephone
619-471-9186Provider last certified this registry record 12 Nov 2025.
Clinical trials
- Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab
Sponsor: University of California, San Diego
- Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)
Sponsor: Adam Burgoyne, MD, PhD
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202514 payments
- Boston Scientific CorporationProgram year202516 payments
- GUERBET LLCProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2018–2018 per NIH RePORTER. The latest:
- A Phase I study of a dual PI3K/BRD4 inhibitor, SF1126 in the treatment of hepatocellular carcinoma IDE: 74,551
University of California, San Diego
FY2018$250,000R01FD005113
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network
2025 - Hyperprogression and Systemic Metastasis of Cholangiocarcinoma after Histotripsy Therapy
Journal of Vascular and Interventional Radiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Victor Nizet, MD
University of San Diego
Christopher Kane, MD
University of San Diego
Lawrence Marshall, MD
University of San Diego
Lyudmila Bazhenova, MD
University of San Diego
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”